发明名称 FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOF
摘要 The invention provided herein includes isolated polypeptides that specifically block the interaction between neonatal Fc receptor (FcRn) and albumin. Blocking the interaction treats diseases and conditions caused by increased amounts of albumin or modified albumin that possesses pathogenic properties wherein it is deemed desirable to decrease albumin levels. Accordingly, also provided are methods of using these isolated polypeptides to treat various diseases and conditions caused by increased amounts of albumin or modified albumin that possesses pathogenic properties. The invention provided herein also includes isolated polypeptides capable of binding to a non-IgG and non-albumin competitive site on an FcRn alpha 3 domain. These can be useful for tracking FcRn without inhibiting IgG or albumin binding or function. Accordingly, the invention also includes methods and systems to track FcRn without inhibiting IgG or albumin binding or function.
申请公布号 US2016122394(A1) 申请公布日期 2016.05.05
申请号 US201414897999 申请日期 2014.06.18
申请人 THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ;BIOGEN IDEC MA INC. 发明人 BLUMBERG Richard S.;RATH Timo;BAKER Kristi;MEZO Adam;TAYLOR Zachary;MCDONNELL Kevin;GRENHA Rosa Maria Silva Garcia
分类号 C07K14/00;G01N33/50;C12N15/10;C07K7/08;C07K14/765 主分类号 C07K14/00
代理机构 代理人
主权项 1. An isolated polypeptide that specifically blocks the interaction between neonatal Fc receptor (FCRN) and albumin comprising at least one peptide subunit consisting of an amino acid sequence X1-Y-X2-C-X3-X4-W-X5-X6-X7-W-C-X8-X9-V-X10-X11 (SEQ ID NO:7), wherein X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, and X11 is each independently selected from any amino acid, or is deleted.
地址 Boston MA US